Seeking Alpha

Unilife reports earnings, MedImmune deal sends shares higher on the day

  • Unilife (UNIS) is flat AH following the release of FQ1 results.
  • CEO Alan Shortall says the $3.2M of revenue the company recorded for the period marks "an inflection point." "From here, I expect the slope to be significant," Shortall adds. (PR)
  • The shares rallied 9.5% during the regular session after the company announced a supply agreement with MedImmune under which UNIS "will supply customized devices from its platform of ReadyToGo wearable injectors."
  • Although UNIS said it would "generate revenue starting in Q1," other financial terms weren't disclosed. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: